|
Stockholders' Equity (Schedule of Warrants) (Details) (Warrant [Member], USD $)
|
6 Months Ended |
|---|---|
|
Oct. 31, 2013
|
|
|
Warrant [Member]
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
| Beginning Balance | 9,090,292 |
| Granted | 9,199,236 |
| Exercised | |
| Forfeited | (40,000) |
| Expired | |
| Ending Balance | 18,249,528 |
| Weighted average exercise price, beginning | $ 0.45 |
| Weighted average exercise price, granted | $ 0.33 |
| Weighted average exercise price, exercised | |
| Weighted average exercise price, forfeited | $ 0.50 |
| Weighted average exercise price, expired | |
| Weighted average exercise price, ending | $ 0.40 |
| Weighted Average Remaining Contractual Term, Outstanding | 4 years 7 months 6 days |
| Aggregate Intrinsic Value, Outstanding | $ 196,123 |
| Exercisable | 18,249,528 |
| Weighted Average Exercise Price, Exercisable | $ 0.40 |
| Weighted Average Remaining Contractual Term, Exercisable | 4 years 7 months 6 days |
| Aggregate Intrinsic Value, Exercisable | $ 196,123 |
| X | ||||||||||
|
- Definition
The number of exercisable warrants (fully vested and expected to vest) that may be converted as of the balance sheet date. No definition available.
|
| X | ||||||||||
|
- Definition
Weighted average price at which grantees can acquire the shares upon exercise of the warrants. No definition available.
|
| X | ||||||||||
|
- Definition
Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
|
- Definition
Weighted average exercise price of warrants exercised No definition available.
|
| X | ||||||||||
|
- Definition
Weighted average exercise price expired No definition available.
|
| X | ||||||||||
|
- Definition
Weighted average exercise price of warrants forfeited. No definition available.
|
| X | ||||||||||
|
- Definition
Weighted average exercise price of warrants granted. No definition available.
|
| X | ||||||||||
|
- Definition
Weighted average price at which grantees can acquire the shares upon exercise of the warrants. No definition available.
|
| X | ||||||||||
|
- Definition
Intrinsic value of equity-based compensation awards outstanding. Excludes stock and unit options. No definition available.
|
| X | ||||||||||
|
- Definition
Intrinsic value of equity-based compensation awards vested. Excludes stock and unit options. No definition available.
|
| X | ||||||||||
|
- Definition
Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Number of non-option equity instruments exercised by participants. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Net number of non-option equity instruments granted to participants. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|